Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies
5
Zitationen
10
Autoren
2022
Jahr
Abstract
Abstract The coronavirus disease 2019 (COVID-19) pandemic resulted in severe interruptions to clinical research worldwide. This global public health crisis required investigators and researchers to rapidly develop and implement new strategies and solutions to mitigate its negative impact on the progress of clinical trials. In this paper, we describe the challenges, strategies, and lessons learned regarding the continuation of a supportive oncology clinical trial during the pandemic. We hope to provide insight into the implementation of clinical trials during a public health emergency to be better prepared for future instances. Trial registration: ClinicalTrials.gov, a service of the US National Institute of Health (NCT 03030859). Registered on 22 January 2017.
Ähnliche Arbeiten
Clinical Characteristics of Coronavirus Disease 2019 in China
2020 · 31.100 Zit.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 · 29.058 Zit.
Cancer statistics, 2023
2023 · 16.439 Zit.
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
2018 · 7.714 Zit.
Factors associated with COVID-19-related death using OpenSAFELY
2020 · 6.706 Zit.